Shanghai Sunland Industrial Co., Ltd is the top manufacturer of Personal Protect Equipment in China, with 20 years’experience. We are the Chinese government appointed manufacturer for government power,personal protection equipment , medical instruments,construction industry, etc. All the products get the CE, ANSI and related Industry Certificates. All our safety helmets use the top-quality raw material without any recycling material.
Can ordinary protective clothing protect against virus
We provide exclusive customization of the products logo, using advanced printing technology and technology, not suitable for fading, solid and firm, scratch-proof and anti-smashing, and suitable for various scenes such as construction, mining, warehouse, inspection, etc. Our goal is to satisfy your needs. Demand, do your best.
Professional team work and production line which can make nice quality in short time.
The professional team provides 24 * 7 after-sales service for you, which can help you solve any problems
BGI’s Real-Time ,Fluorescent, RT-,PCR, kit for detecting 2019-nCoV(SARS-CoV-2) is a qualitative in vitro nucleic acid amplification assay used to detect SARS-CoV-2 using reverse transcription ,PCR, from throat swab and Bronchoalveolar Lavage Fluid（BALF） samples. The kit is widely used for rapid ,detection, and outbreak control of COVID-19 in China.
15/4/2020, · Almost the entire world, not only China, is currently experiencing the outbreak of a ,novel coronavirus, that causes respiratory disease, severe ,pneumonia,, and even death. The outbreak began in Wuhan, China, in December of 2019 and is currently still ongoing. This ,novel coronavirus, is highly contagious and has resulted in a continuously increasing number of infections and deaths that have ...
Identification of a ,novel coronavirus, causing severe ,pneumonia, in human: a descriptive study. Chin Med J 2020;133:1015–1024. doi: 10.1097/CM9.0000000000000722. Received 25 January, 2020. Li-Li Ren, Ye-Ming Wang, Zhi-Qiang Wu, Zi-Chun Xiang, Li Guo, Teng Xu, Yong-Zhong Jiang, and Yan Xiong contributed equally to this work.
Due to the increasing rates of oropharyngeal cancer, oral ,HPV, infection is a significant concern. Methods for detecting oral HPVs is not standardized as there are different techniques available. We propose that use of oral rinse samples to detect for HPVs is a suitable technique within a clinic setting. Thus, our main objective is to study ,HPV detection, in oral rinse samples.
1/3/2020, · Measures for diagnosing and treating infections by a ,novel coronavirus, responsible for a ,pneumonia, outbreak ... the S protein has been evaluated in ,different types, of vaccines against ... Currently, however, no diagnostic ,test kit, is available for the detection of antibodies to 2019-nCoV. Declaration of Competing Interest.
Detection, of high-risk (HR) genotypes associated with the development of cervical cancer Aids in triaging women with abnormal Pap smear results Individual genotyping ,of human papillomavirus, (,HPV,)-16 and/or ,HPV,-18, if present Results ,of HPV,-16 and ,HPV,-18 genotyping can aid in triaging women with positive HR-,HPV, but negative Pap smear results
Diagnosis and Treatment Protocol for ,Novel Coronavirus Pneumonia, (Trial Version 7) (Released by National Health Commission & State Administration of Traditional Chinese Medicine on March 3, 2020) Since December 2019, ,multiple, cases of ,novel coronavirus pneumonia, (NCP) …
Novel coronavirus, SARS-CoV-2, designated as ,COVID-19, by the World Health Organization (WHO) on the February 11, 2020, is one of the highly pathogenic β‐,coronaviruses, which infects human. Early diagnosis of ,COVID-19, is the most critical step to treat infection. The diagnostic tools are generally molecular methods, serology and viral culture.
21/4/2020, · For ,the novel coronavirus,, FDA chose to limit the initial approval to the CDC ,test, for the purpose of ensuring accurate surveillance testing by state and local public health laboratories. 3 The failure of this ,test,, however, put into sharp relief the risks of this strategy: inadequate capacity to conduct surveillance, as well as a challenge to scale up quickly should the ,test, be needed broadly ...